We are here at #Atto22 in sunny Orlando, Florida! Thank you @ProfMChini for inviting us! Looking forward to all the amazing talks! Great first day with a fascinating talk by our 1st year PhD student Josh!. Congratulations, Josh!
A new anti-cancer drug that targets a common genetic abnormality has shown promise in a study of mouse and human tumours. The research, which includes the first known report of KRAS inhibitor treatment in human clinical trials, is revealed in Nature. https://t.co/GNDVA6iKOc
#ClimateChange is already having a dramatic effect on many ecosystems, leading to questions about what the future will bring. Learn more in this new report exploring these topics: https://t.co/mah4KdQOSP
A team of researchers has generated and characterized a new form of light that can clearly identify molecules’ handedness, or chirality.
@TechnionLive#biophotonics#photonics
https://t.co/C6Bqd28ufv